Men | Women | |||
---|---|---|---|---|
OR | 95% CI | OR | 95% CI | |
ApoA1/HDL-C | ||||
Mid-tertile | 1.50 | 0.73-3.08 | 1.24 | 0.69-2.21 |
Top-tertile | 2.98 | 1.12-7.92 | 2.15 | 1.00-4.59 |
P-trend | 0.030 | 0.047 | ||
ApoB/ApoA1 | ||||
Mid-tertile | 0.96 | 0.43-2.15 | 0.65 | 0.33-1.24 |
Top-tertile | 0.83 | 0.27-2.59 | 0.54 | 0.21-1.40 |
P-trend | 0.731 | 0.213 | ||
LDL-C/HDL-C | ||||
Mid-tertile | 1.08 | 0.52-2.23 | 0.96 | 0.54-1.72 |
Top-tertile | 0.79 | 0.28-2.27 | 0.70 | 0.30-1.64 |
P-trend | 0.678 | 0.431 | ||
ApoB/LDL-C | ||||
Mid-tertile | 1.54 | 0.78-3.02 | 1.46 | 0.83-2.55 |
Top-tertile | 1.69 | 0.79-3.62 | 2.03 | 1.07-3.85 |
P-trend | 0.198 | 0.028 | ||
ApoA1 | ||||
Mid-tertile | 0.81 | 0.45-1.45 | 0.88 | 0.51-1.50 |
Top-tertile | 0.87 | 0.41-1.85 | 1.52 | 0.78-2.96 |
HDL-C | ||||
Mid-tertile | 0.70 | 0.31-1.56 | 0.98 | 0.55-1.74 |
Top-tertile | 1.12 | 0.36-3.50 | 0.81 | 0.33-1.95 |
ApoB | ||||
Mid-tertile | 0.70 | 0.28-1.71 | 1.53 | 0.73-3.20 |
Top-tertile | 1.45 | 0.44-4.81 | 1.95 | 0.67-5.68 |
LDL-C | ||||
Mid-tertile | 1.45 | 0.66-3.20 | 0.98 | 0.50-1.92 |
Top-tertile | 0.99 | 0.36-2.76 | 1.05 | 0.43-2.59 |
TG | ||||
Mid-tertile | 1.06 | 0.55-2.03 | 0.45 | 0.26-0.79 |
Top-tertile | 1.02 | 0.49-2.11 | 0.55 | 0.30-0.99 |
WHR | ||||
Mid-tertile | 0.77 | 0.37-1.62 | 0.99 | 0.54-1.81 |
Top-tertile | 1.00 | 0.48-2.09 | 1.54 | 0.83-2.87 |
Age < 45 | - | - | - | - |
45 ≤ Age < 60 | 2.15 | 1.19-3.88 | 1.11 | 0.65-1.87 |
Age ≥ 60 | 3.77 | 2.01-7.07 | 1.55 | 0.86-2.80 |
Exercise habits | 0.78 | 0.47-1.28 | 1.20 | 0.78-1.85 |
SBP | 1.00 | 0.98-1.02 | 1.01 | 0.99-1.02 |
DBP | 0.99 | 0.96-1.02 | 0.98 | 0.96-1.01 |
FPG | 1.13 | 1.11-1.15 | 1.11 | 1.09-1.12 |
UA | 0.94 | 0.82-1.07 | 1.05 | 0.93-1.18 |
CREA | 0.93 | 0.62-1.42 | 1.39 | 1.03-1.87 |